Elan Pharmaceuticals (ELN) Lab Liquidation Auctions -- South San Francisco Closure; to be Hosted by BioSurplus on Its Secure Online Auction Platform
1/9/2013 9:42:25 AM
More...
|
Elan Pharmaceuticals (ELN) Announces Webcast of Fourth Quarter and Full-Year 2011 Financial Results
1/26/2012 6:47:25 AM
More...
|
Elan Pharmaceuticals (ELN) Pays Transition Therapeutics Inc. (TTH.TO) $9M in Amended Deal for Phase II Alzheimer Candidate; Transition Eligible for $11 Million More
12/27/2010 7:40:40 AM
More...
|
Infosys Technologies and Elan Pharmaceuticals (ELN) Apply Co-creation Model to Transform Discovery Research
2/2/2010 9:27:18 AM
More...
|
Elan Pharmaceuticals (ELN) Reports Fourth Quarter and Full-Year 2007 Financial Results
2/13/2008 8:58:29 AM
More...
|
Elan Pharmaceuticals (ELN) Selects Medidata Solutions, Inc. Rave(R) to Support Clinical Development Activities
12/17/2007 9:09:34 AM
More...
|
Elan Pharmaceuticals (ELN) Joins GeneGo, Inc.'s MetaTox Consortium
11/27/2007 9:21:22 AM
More...
|
Elan Pharmaceuticals (ELN) Licenses Software and Databases From GeneGo, Inc.
10/30/2007 7:59:31 AM
More...
|
Tripos Discovery Research Ltd. (TRPS), a Subsidiary of Commonwealth Biotechnologies, Inc. (CBTE), Signs Library Analysis Agreement with Elan Pharmaceuticals (ELN)
8/9/2007 12:24:11 PM
More...
|
Alzheimer's Drug Discovery Foundation and Elan Pharmaceuticals (ELN) Announce Winners of Second Annual Novel Discovery Award Program
3/1/2007 12:45:53 PM
More...
|
|